Human Genetics

, Volume 123, Issue 3, pp 307–313 | Cite as

Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease

  • Steven Wiltshire
  • Brenda L. Powell
  • Michelle Jennens
  • Pamela A. McCaskie
  • Kim W. Carter
  • Lyle J. Palmer
  • Peter L. Thompson
  • Brendan M. McQuillan
  • Joseph Hung
  • John P. Beilby
Original Investigation

Abstract

Endothelin-1 is a potent vasoconstrictor in the body. Previous studies have identified associations between the coding polymorphism K198N and hypertension, systolic blood pressure and HDL levels. We sought to examine the evidence for these associations and, additionally, the association between K198N, insulin resistance, metabolic syndrome and coronary artery disease (CAD). We used generalised linear modelling to test K198N for association with hypertension and systolic blood pressure, lipid levels, insulin resistance scores and metabolic syndrome in a general cross-sectional community sample. Mean carotid intima media thickness and risk of carotid plaque were examined in the general population sample, and Gensini score was examined in a sample of patients with CAD. A case/control sample was used to examine the association of K198N with risk of CAD. There was no significant evidence for association between K198N and hypertension, systolic blood pressure, lipid levels, insulin resistance or metabolic syndrome in either population. The minor allele was marginally associated with increased mean IMT levels (P = 0.02) in the general population sample, although not with CAD in the case/control study or with the severity of disease in patients with CAD. In conclusion, we found no robust evidence for the associations between K198N and hypertension, systolic blood pressure or HDL levels seen in previous studies.

Notes

Acknowledgments

The authors thank the participants of the CUPID and CUDAS cross sectional studies. This study was supported by grants-in-aid from the National Heart Foundation grant-in-aid G97P 5002. K.W.C. was supported by a Post-doctoral Fellowship from the Australian Research Council. B.L.P. was supported by a Howard Florey Fellowship from the National Health and Medical Research Council of Australia.

References

  1. Alberti KG, Zimmet P, Shaw J (2005) IDF epidemiology task force consensus group: the metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062PubMedCrossRefGoogle Scholar
  2. Asai T, Ohkubo T, Katsuya T, Higaki J, Fu Y, Fukuda M, Hozawa A, Matsubara M, Kitaoka H, Tsuji I, Araki T, Satoh H, Hisamichi S, Imai Y, Ogihara T (2001) Endothlin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 38:1321–1324PubMedCrossRefGoogle Scholar
  3. Carter KW, McCaskie PA, Palmer LJ (2006) JLIN: a Java based linkage disequilibrium plotter. BMC Bioinformatics 7:60PubMedCrossRefGoogle Scholar
  4. Chapman CM, Palmer LJ, McQuillan BM, Hung J, Burley J, Hunt C, Thompson PL, Beilby JP (2001) Polymorphisms in the angiotensinogen gene are associates with carotid intimal-media thickening in females from a community-based population. Atherosclerosis 159:209–217PubMedCrossRefGoogle Scholar
  5. Dupont WD, Plummer WD (1990) Power and sample size calculations: a review and computer program. Control Clin Trials 11:116–128PubMedCrossRefGoogle Scholar
  6. Endeman DK, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992CrossRefGoogle Scholar
  7. Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606PubMedCrossRefGoogle Scholar
  8. Grundy SM, Brewer B Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438PubMedCrossRefGoogle Scholar
  9. Irving RJ, Noon JP, Watt GC, Webb DJ, Walker BR (2001) Activation of the endothelin system in insulin resistance. QJM 94:321–326PubMedCrossRefGoogle Scholar
  10. Jin JJ, Nakura J, Wu Z, Yamamoto M, Abe M, Tabara Y, Yamamoto Y, Igase M, Kohara K, Miki T (2003) Association of endothelin-1 gene variant with hypertension. Hypertension 41:163–167PubMedCrossRefGoogle Scholar
  11. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846PubMedCrossRefGoogle Scholar
  12. Kanaya AM, Barret-Connor E, Wassel Fyr CL (2007) Endothelin-1 and prevalent coronary heart disease in older mend and women (The Rancho Bernardo Study). Am J Cardiol 4:486–490CrossRefGoogle Scholar
  13. Langleben D (2007) Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. Clin Chest Med 28:117–125PubMedCrossRefGoogle Scholar
  14. Luscher TF, Barton M (2000) Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102:2434–2440PubMedGoogle Scholar
  15. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefGoogle Scholar
  16. McCaskie PA, Cadbuy G, Hung J, McQuillan BM, Chapman CML, Carter KW, Thompson PL, Palmer LJ, Beilby (2006) The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease. Clin Genet 70:114–121PubMedCrossRefGoogle Scholar
  17. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J (1999) Hyperhomocysteinaemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 99:2838–2888Google Scholar
  18. Paré G, Serre D, Brisson D, Anand SS, Montpetit A, Tremblay G, Engert JC, Hudson TJ, Gaudet D (2007) Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high density lipoprotein cholesterol. Am J Hum Genet 80:673–682PubMedCrossRefGoogle Scholar
  19. Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149–150PubMedCrossRefGoogle Scholar
  20. Shah R (2007) Endothelins in health and disease. Eur J Int Med 18:272–282CrossRefGoogle Scholar
  21. Strawbridge AB, Elmendorf JS (2005) Phosphatidylinositol 4,5 bisphosphate reverse endothelin-1 induced insulin resistance via an actin-dependent mechanism. Diabetes 54:1698–1705PubMedCrossRefGoogle Scholar
  22. Strawbridge AB, Elmendorf JS (2006) Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism. J Cell Biol 97:849–856Google Scholar
  23. Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJV, Dargie HJ, Arveiler D, Ruidavets J-B, Luc G, Evans A, Cambien F (1999) The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33:1169–1174PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Steven Wiltshire
    • 1
    • 2
  • Brenda L. Powell
    • 1
  • Michelle Jennens
    • 5
  • Pamela A. McCaskie
    • 1
    • 3
  • Kim W. Carter
    • 1
  • Lyle J. Palmer
    • 1
    • 2
  • Peter L. Thompson
    • 2
    • 4
  • Brendan M. McQuillan
    • 2
    • 4
  • Joseph Hung
    • 2
    • 4
  • John P. Beilby
    • 5
    • 6
  1. 1.Western Australian Institute for Medical Research and UWA Centre for Medical ResearchUniversity of Western AustraliaPerthAustralia
  2. 2.School of Medicine and PharmacologyUniversity of Western AustraliaPerthAustralia
  3. 3.School of Mathematics and StatisticsUniversity of Western AustraliaPerthAustralia
  4. 4.Sir Charles Gairdner Hospital Campus of the Heart Institute of Western AustraliaPerthAustralia
  5. 5.Clinical Biochemistry, PathWestNedlandsAustralia
  6. 6.School of Surgery and PathologyUniversity of Western AustraliaPerthAustralia

Personalised recommendations